Lab-grown Cordyceps militaris fruiting bodies, low-temperature dried at 40–50 °C to preserve the full bioactive profile. Available as raw fruiting body for extractors and as a 10:1 extract standardized to cordycepin, HPLC-verified on every lot.
Whole, low-temperature-dried fruiting bodies, size-graded and hand-sorted — the raw input for extractors, formulators and specialty tea houses.
| Grade | Standardization spec | Appearance |
|---|---|---|
| Grade 1 · whole / cut | Beta-glucan 8.4% (gravimetric); moisture < 10% | Orange whole or cut fruiting bodies |
10:1 concentrate standardized to cordycepin and verified by HPLC on every lot; a fine powder for capsules, functional beverages and blends.
| Grade | Standardization spec | Appearance |
|---|---|---|
| 10:1 · ISO A | Cordycepin ≥ 0.3% (HPLC); moisture < 8% | Fine free-flowing powder |
Cordycepin and adenosine engage the same pathways as cellular ATP metabolism, the basis of cordyceps' study alongside oxygen utilisation and endurance.
Beta-glucan fibres in the fruiting body are recognised by immune-cell receptors — the reason mushroom material is studied beyond nutrition.
Traditionally used for respiratory support; the standardized marker lets a formulator specify a reproducible dose.
Standardized extract for capsules, tablets and functional-supplement lines.
Functional beverages, broths and adaptogenic blends.
Adaptogenic actives for skin-energy and antioxidant positioning.
High-temperature drying at 85–105 °C — used by most manufacturers — causes cordycepin and adenosine to leach out as steam. What remains looks identical but is nutritionally depleted. Our 40–50 °C protocol preserves the compounds you are paying for.
Most cordyceps on the market is mycelium grown on rice or oats, then ground whole — 40–80% of that powder is grain starch, not mushroom. Ours is made exclusively from the orange fruiting body: the part that carries the cordycepin.
Not recommended for pregnant or breastfeeding women, or individuals on blood thinners or immunosuppressants — consult a physician. Reported benefits are informational and not evaluated as medical claims.
A forward-looking summary of expected regulatory movement — scheduled to publish once finalised.
Dose targets, excipient choices, and the QA checks that keep a cordycepin claim defensible from pilot batch to production.
The adenosine analogue behind cordyceps' energy and endurance claims — and what HPLC actually measures.